Pharmaceutical giant AstraZeneca has been released from a whistleblower suit in federal court in Philadelphia.
Because the relator in the qui tam action didn’t satisfy the standard for being an original source with direct and independent knowledge of the company’s alleged violation of the False Claims Act and because essentially identical allegations have already been made in other lawsuits and in newspaper reports, the claims can’t survive the public disclosure bar, U.S. District Judge J. William Ditter Jr. of the Eastern District of Pennsylvania has ruled.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
